Previous Advocacy Updates

The CMS proposed its 2019 Medicare Physician Fee Schedule and new rules for next year’s Merit-based Incentive Payment System (MIPS).

The CMS sets enforcement discretion period for Laboratory Date of Service Policy and eligible pathologists can request targeted review of their 2019 MIPS Payment Adjustments.

The CAP advocated for fair clinical laboratory payments for new CPT codes for the CMS to consider including in the 2019 Medicare clinical laboratory fee schedule (CLFS).

The CAP advocated for the CMS to revise its proposed inpatient payment system regulation that would make hospital standard charges public, increase emphasis on interoperability of HIT, ensure consistent payment rates for CAR-T cell therapy settings, and further extend its “14-day rule” policy to allow laboratories to bill directly for molecular pathology tests. Moreover, CAP members and leaders continue to urge their elected officials to support legislation to increase transparency and accountability in the Medicare Local Coverage Determination (LCD) process.

AMA Special Report: CAP Protects Accurate Diagnoses for Patients at 2018 AMA Meeting.

CAP leads support of Health Plan Network Adequacy with multiple patient advocacy groups and NJ governor signs balance billing measure into law.

2018 MIPS reporting resources now available for Pathologists.

Pathologists’ action leads to more LCD reform support and CMS to release 2017 MIPS scores on July 1.

MIPS clinician eligibility tool available for Individuals and Group Practices

Pathologists lobby for Medicare LCD, PAMA reform at 2018 Hill Day

Pathologists to advocate for LCD, PAMA Reform at the 2018 Policy Meeting

CAP and other specialty societies Ask CMS to reduce 2018 MIPS reporting period

It’s not too late to be heard at the 2018 Policy Meeting and earn 6.5 CMEs.

Recently CAP leaders met with top CMS officials to discuss the challenges pathologists face when participating in Medicare’s Quality Payment Program.

In testimony delivered to an FDA advisory committee on March 30, the CAP supported the use of capillary blood with blood glucose meters for critically-ill hospital patients in certain instances.

The CAP calls for revisions to “14-day rule” policy to allow laboratories to directly bill for molecular pathology and advanced diagnostic tests regardless of the place of service.

The CMS Addresses the CAP’s Concerns on NGS Coverage.

The CAP engages with CMS on potential CLIA regulations on lab personnel.

Having issues reporting MIPS? The CMS wants to hear from you!

The CAP files Amicus Brief in support of ACLA Motion for Summary Judgement in PAMA lawsuit.